b'Chris Atkins and Brian Tanquilut talk takeaways from Walgreens second quarter report, with shares closing down 5.7% Thursday. The pharmacy retailer announced that a strategic review of its Boots business is underway, and also reaffirmed its FY22 EPS guidance in the low-single digits.'